Investment Rating - The investment rating for the company is "Buy" and is maintained [9] Core Views - The company's cumulative electricity sales volume for 2025 is expected to reach 226.79 billion kWh, representing a year-on-year increase of 7.00%. In the second half of 2025, the sales volume is projected to be 124.81 billion kWh, with a year-on-year growth of 9.77%. The growth rate of electricity sales in the second half of 2025 shows significant improvement compared to the first half, indicating a stable revenue growth outlook despite downward pressure on electricity prices [2][10] - The company is expected to face some pressure on its overall performance in 2025 due to weak coal production in the first half and a high base effect from the previous year. However, the decline in performance is anticipated to narrow [2][10] - The company has seen a steady increase in electricity sales across various sources: thermal power sales reached 157.79 billion kWh (up 1.3%), wind power sales reached 53.70 billion kWh (up 16.4%), solar power sales reached 13.20 billion kWh (up 55.5%), and hydropower sales reached 2.09 billion kWh (up 35.9%) [6][10] - The company has been expanding its renewable energy capacity, with a total of 4.839 million kW of new wind and solar installations added in the first half of 2025. As of June 30, 2025, the company has 8.679 million kW of wind and 6.515 million kW of solar capacity under construction, ensuring growth potential [10] Summary by Sections Sales Volume and Revenue Outlook - The company expects stable growth in electricity sales volume for 2025, with a total of 226.79 billion kWh, and a significant improvement in the growth rate in the second half of the year [2][10] - Revenue growth is expected to be steady, although it may lag behind the growth in electricity sales due to downward pressure on electricity prices [2][10] Cost Management and Performance - Fuel costs are expected to maintain a year-on-year decline, with the average price of coal at Qinhuangdao Port at 716.77 RMB/ton, down 118.97 RMB/ton year-on-year. This cost optimization is expected to support the company's thermal power operations [10] - Despite some challenges, the overall performance decline for 2025 is expected to narrow compared to the first half of the year [2][10] Growth and Dividend Policy - The company has a consistent dividend policy, with a mid-year dividend of 0.356 HKD per share, reflecting its commitment to shareholder returns [10] - The orderly expansion of renewable energy capacity is expected to provide growth opportunities for the company [10]

Investment Rating - The report maintains a "Buy" rating for the company [5][7]. Core Views - The company demonstrated resilience in operations despite industry pressures, with a focus on health consumer products and prescription drugs showing growth [2]. - The company is positioned as a leading player in the OTC market for gastrointestinal products in China, with expectations for steady growth through both organic and external means [1]. - The company has implemented cost optimization strategies that have led to improved profitability and stable cash flow [3]. Summary by Sections Financial Performance - For the first half of 2025, the company reported revenues of 2.14 billion RMB, a decrease of 6% year-on-year, while net profit attributable to shareholders was 520 million RMB, an increase of 6% year-on-year [1]. - The second quarter of 2025 saw revenues of 960 million RMB, a decline of 4% year-on-year, but net profit attributable to shareholders increased by 6% to 240 million RMB [1]. - The gross margin for the first half of 2025 was 66.6%, down 2.4 percentage points year-on-year, primarily due to a decrease in the proportion of high-margin OTC business [3]. Business Segments - The OTC segment faced challenges with revenues of 1.55 billion RMB, down 10% year-on-year, while health consumer products grew by 17% to 230 million RMB, and prescription drugs increased by 7% to 360 million RMB [2]. - The company has strengthened its online marketing channels and brand building, which contributed to the growth in health consumer products [2]. Dividend Policy - The company announced a cash dividend of 0.5 RMB per share for the first half of 2025, representing 60.78% of the net profit attributable to shareholders [1][4]. - The company plans to maintain a high dividend payout ratio during the 14th Five-Year Plan period, emphasizing its commitment to shareholder returns [4]. Future Outlook - The company forecasts net profits attributable to shareholders of 897 million RMB, 1.015 billion RMB, and 1.145 billion RMB for 2025, 2026, and 2027, respectively, reflecting growth rates of 14%, 13%, and 13% year-on-year [5]. - The target price for the company's stock is set at 29.96 RMB, based on a 21x PE ratio for 2025 [5].

Investment Rating - The report assigns a "Buy" rating to the company [10]. Core Insights - Yuehai Investment is a Guangdong state-owned enterprise with a strong portfolio in water supply to Hong Kong, holding a 30-year concession for the Dongshen Water Supply Project, which accounts for 70%-80% of local freshwater usage. The company is expected to enter a stable dividend phase by 2025, with an estimated dividend yield of 6.77% [3][6]. Summary by Sections Company Overview - Yuehai Investment is primarily focused on water resources, with the Guangdong provincial government holding a 58.27% stake. The company operates five main business segments, with the water resources segment contributing 81% to the overall pre-tax profit. The Dongshen Water Supply Project is the core asset, providing stable cash flow [6][16]. Water Resources - The Dongshen Water Supply Project has a supply capacity of 2.423 billion cubic meters annually, supplying 70%-80% of Hong Kong's freshwater and over 50% of Shenzhen's water. The project is expected to generate 39% of its total supply to Hong Kong in 2024, contributing 81% to the project's total revenue [7][36]. Other Water Projects - Other water resource projects have entered a stable operational phase, with a design capacity of 5.895 billion tons/year for water supply and 1.221 billion tons/year for sewage treatment. Revenue from construction has declined significantly, indicating a shift to stable operations [8][30]. Other Business Segments - The performance of other business segments has stabilized after the removal of factors causing volatility. The contributions to pre-tax profit from various segments are 81% from water resources, 10% from property investment, and smaller percentages from other sectors [9][23]. Financial Analysis & Profit Forecast - The company is projected to achieve a sustainable net profit of HKD 4.1 billion in 2024, with a debt ratio of 30.9% by the end of 2024. The dividend payout ratio is expected to remain at 65% for 2023-2024, with forecasted net profits of HKD 4.54 billion, HKD 4.75 billion, and HKD 4.83 billion for 2025-2027, respectively [10][28].